Nystatin and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nystatin (nystatin) and Repaglinide (repaglinide). Common drug interactions include cognitive disorder among females and hepatitis fulminant among males.

The phase IV clinical study analyzes what interactions people have when they take Nystatin and Repaglinide. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,568 Nystatin users. Check the latest studies of Nystatin.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

35 people who take Nystatin and Repaglinide together, and have interactions are studied.

Nystatin and Repaglinide drug interactions.

What are the common drug interactions of Nystatin and Repaglinide, by gender? *:

female:

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Colitis (inflammation of colon)
Complications of transplanted kidney
Cystic fibrosis (disease of the secretary glands)
Dependent personality disorder
Depressed mood
Device dislocation
Diarrhoea
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Drug hypersensitivity

male:

Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
Cellulitis (infection under the skin)
Coma hepatic (accumulation in the bloodstream of toxic substances that are normally removed by the liver leads coma)
Death
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Dysphagia (a condition in which swallowing is difficult or painful)
Fatigue (feeling of tiredness)
Hepatitis b
Herpes zoster
Infection

What are the common drug interactions of Nystatin and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Affective disorder (mental disorder)
Alanine aminotransferase increased
Alopecia (absence of hair from areas of the body)
Aspartate aminotransferase increased
Blood bilirubin increased
Blood pressure increased
Bronchial secretion retention
Cystic fibrosis (disease of the secretary glands)
Depression
Device dislocation

50-59:

Septic shock (shock due to blood infection)
Thrombocytopenia (decrease of platelets in blood)
Unresponsive to stimuli
Cellulitis (infection under the skin)
Lymphangitis (inflammation of the lymph channel)
Neuropathic ulcer (nerve damage in foot leads to sensation loss and person puts lots of pressure and gets ulcer)
Oedema peripheral (superficial swelling)
Diabetes mellitus inadequate control
Blood glucose decreased
Death

60+:

Pneumonia
Acute respiratory failure
Blood urea increased
Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)
Contusion (a type of hematoma of tissue in which capillaries)
Femur fracture
Flatulence (flatus expelled through the anus)
Haemoglobin decreased
Injury
Joint range of motion decreased (disease of joint movement)

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 28.57%
Cough: 9 people, 25.71%
Type 2 Diabetes: 8 people, 22.86%
Insomnia (sleeplessness): 6 people, 17.14%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 17.14%
Back Pain: 6 people, 17.14%
Arrhythmias (irregular heartbeat): 4 people, 11.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 11.43%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 11.43%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously